AUTOLOGOUS STEM CELL TRANSPLANTATION IS SAFE AND EFFECTIVE FOR OLDER MYELOMA PATIENTS: RESULTS FROM THE MYELOMA XI TRIAL

EHA Library, Charlotte Pawlyn, 214501

PHARMACOLOGIC DISPLACEMENT OF LSD1 FROM GFI1 ACTIVATES PRIMED ENHANCERS TO INDUCE DIFFERENTIATION IN ACUTE MYELOID LEUKEMIA

EHA Library, Alba Maiques Diaz, 214508

THE ROLE OF MINIMAL RESIDUAL DISEASE AT THE TIME OF TRANSPLANTATION IN PATIENTS WITH AML IN CR2 AFTER ALLOGENEIC STEM CELL TRANSPLANTATION. A STUDY OF THE ACUTE LEUKEMIA WORKING PARTY OF THE EBMT.

EHA Library, Arnon Nagler, 214511

FREQUENT IMMUNOGLOBULIN REARRANGEMENT, JAK1/2 INHIBITION AND AGGRESSIVE B-CELL LYMPHOMA DEVELOPMENT IN PATIENTS WITH MYELOFIBROSIS

EHA Library, Veronika Sexl, 214513

CLINICAL-GRADE PRODUCTION, PRECLINICAL EFFICACY AND SAFETY OF ALLOGENEIC CD19CAR CYTOKINE-INDUCED KILLER CELLS TRANSFECTED WITH SLEEPING BEAUTY TRANSPOSON FOR ACUTE LYMPHOBLASTIC LEUKEMIA TREATMENT

EHA Library, Chiara F Magnani, 214515

FACTORS INFLUENCING MANAGEMENT OF ANTIPLATELET DRUGS IN THROMBOCYTOPENIC PATIENTS WITH HEMATOLOGICAL MALIGNANCY

EHA Library, Avi Leader, 214517

PRETREATMENT VITAMIN D DEFICIENCY IS ASSOCIATED WITH LOWER PROGRESSION-FREE AND OVERALL SURVIVAL IN PROSPECTIVELY TREATED HODGKIN LYMPHOMA

EHA Library, Sven Borchmann, 214592

INTERIM UPDATE FROM A PHASE 2 MULTICENTER STUDY OF TAZEMETOSTAT, AN EZH2 INHIBITOR, IN PATIENTS WITH RELAPSED OR REFRACTORY (R/R) FOLLICULAR LYMPHOMA (FL)

EHA Library, Gilles Salles, 214434

A ROLE OF PIEZO1 IN ERYTHROID DIFFERENTIATION OF NORMAL AND HEREDITARY XEROCYTOSIS DERIVED HEMATOPOIETIC PROGENITORS.

EHA Library, Alexis Caulier, 214445

PRE-CLINICAL RESULTS OF A HUMANIZED CART-BCMA FOR MULTIPLE MYELOMA PATIENTS

EHA Library, Lorena Pérez Amill, 214493

A TRIPLET BORTEZOMIB- AND IMMUNOMODULATOR-BASED THERAPY BEFORE AND AFTER DOUBLE ASCT IMPROVES OVERALL SURVIVAL OF NEWLY DIAGNOSED MM PATIENTS: FINAL ANALYSIS OF PHASE 3 GIMEMA-MMY-3006 STUDY

EHA Library, Paola Tacchetti, 214500

FINAL ANALYSIS OF THE AHL2011 RANDOMIZED PHASE III LYSA STUDY COMPARING AN EARLY PET DRIVEN TREATMENT DE-ESCALATION TO A NOT PET-MONITORED STRATEGY IN PATIENTS WITH ADVANCED STAGES HODGKIN LYMPHOMA

EHA Library, Olivier CASASNOVAS, 214504

BUSULFAN + MELPHALAN WAS ASSOCIATED WITH A LONGER PFS COMPARED TO MELPHALAN ALONE IN HIGH-RISK MULTIPLE MYELOMA IN A RANDOMIZED PHASE 3 CLINICAL TRIAL

EHA Library, Muzaffar H. Qazilbash, 214510

VERY LONG-TERM RESULTS OF ALL-TRANS RETINOIC ACID AND ARSENIC TRIOXIDE THERAPY IN NON-HIGH RISK ACUTE PROMYELOCYTIC LEUKEMIA: LATEST UPDATE OF THE ITALIAN-GERMAN APL0406 RANDOMIZED TRIAL

EHA Library, Laura Cicconi, 214593

PROGNOSTIC AND BIOLOGIC SIGNIFICANCE OF CIRCULAR RNA PROFILING IN YOUNGER ADULT PATIENTS WITH CYTOGENETICALLY NORMAL ACUTE MYELOID LEUKEMIA (CN-AML)

EHA Library, Dimitrios PAPAIOANNOU, 214594

COMPARATIVE PERFORMANCE OF PROGNOSTIC SYSTEMS IN PATIENTS WITH MYELOFIBROSIS SECONDARY TO PV AND ET AFTER ALLOGENEIC STEM-CELL TRANSPLANTATION

EHA Library, Nico Gagelmann, 214597

COMPARISON OF STANDARD- AND LOW-DOSE RITUXIMAB IN PRIMARY IMMUNE THROMBOCYTOPENIA (ITP): DATA FROM THE UK ITP REGISTRY

EHA Library, Caitlin Gracie, 214599

Blood transfusion in patients with sickle cell disease

EHA Library, Karina Yazdanbakhsh, 219112

Next generation sequencing (NGS) for MRD detection in acute lymphoblastic leukemia

EHA Library, Jan Trka, 219419

Preventing (recurrent) thrombosis without bleeding

EHA Library, Harry Büller, 219111

Managing anti-thrombotic therapy in thrombocytopenic cancer patients: a double edged sword

EHA Library, Avi Leader, 219110

Multiple roles of LMWH in managing cancer-associated thrombosis

EHA Library, Stephan Schneider, 219109

High throughput flow cytometry for combined MRD measurements and immune monitoring

EHA Library, Alberto Orfao, 219107

Droplet digital (dd) PCR for improved MRD measurements

EHA Library, Daniela Drandi, 219106

Introduction: Technical innovations in MRD measurements

EHA Library, Jaques J. M. van Dongen, 219105

Flow cytometry for Minimal/Measurable Residual Disease Detection (MRD) in Chronic Lymphocytic Leukaemia (CLL)

EHA Library, Andy Rawstron, 219103

Flowcytometric analysis of minimal residual disease in multiple myeloma

EHA Library, Vincent Velden, van der, 219102

Morphology of multiple myeloma, a patchy disease

EHA Library, Gina Zini, 219101

Evolving gene therapy for primary immunodeficiency

EHA Library, Adrian Thrasher, 219099

Update on congenital neutropenia

EHA Library, Karl Welte, 219098

Immune development during fetal life and beyond, in health and disease

EHA Library, Raz Somech, 219097

Anemia in the elderly

EHA Library, Domenico Girelli, 219091

Genetics and genomics of erythrocyte membrane defects / Structural defects in RBCs

EHA Library, Patrick Gallagher, 219090

Metabolic defects of the red blood cell

EHA Library, R van Wijk, 219089

Clinical trials in hemoglobinopathies

EHA Library, Miguel Abboud, 219087

Epidemiology in sickle cell disease - Lessons learned from a multinational cohort in sub-Saharan Africa

EHA Library, brigitte ranque, 219086

Regulation of gene expression in hematopoiesis

EHA Library, Douglas HIGGS, 219085

The spleen in sickle cell disease

EHA Library, Valentine Brousse, 219083

The spleen in myeloproliferative neoplasms

EHA Library, Pierre Buffet, 219082

The role of the spleen in ITP

EHA Library, James Bussel, 219081

New treatment options

EHA Library, Uwe Platzbecker, 219079

Molecular genetics in clinical decision making

EHA Library, Mario Cazzola, 219078

The hematopoietic niche in MDS: from concept to therapeutic target

EHA Library, Marc Raaijmakers, 219077

Efficacy, safety and accessibility to CAR-T therapy for lymphomas

EHA Library, Peter Borchmann, 219075

Biomarkers for immune checkpoint blockers

EHA Library, Margaret Shipp, 219074

Prediction versus empirical discovery: Lessons learned from the lymphoma neoantigen hunt

EHA Library, Joshua Elias, 219073

CORRELATION BETWEEN IGHV MUTATIONAL STATUS AND AID “ON-TARGET” MOTIFS (WGCW) COUNT IN A SPANISH CLL COHORT

EHA Library, Azahara Fuentes, 215961

ANALYSIS OF THE 3′UTR REGION OF THE NOTCH1 GENE IN CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS

EHA Library, Nadia Bilous, 215962

EXPRESSION OF THE GENES OF THE MAIN RECEPTORS AND LIGANDS OF THE EXTERNAL PATHWAY OF APOPTOSIS IN PATIENTS WITH NEWLY DIAGNOSED CHRONIC LYMPHOCYTIC LEUKEMIA DURING RFC THERAPY

EHA Library, Sergey Zakharov, 215963

DETECTION OF MEASURABLE RESIDUAL DISEASE BY NEXT-GENERATION SEQUENCING IN PAIRED BLOOD AND BONE MARROW SAMPLES FROM PATIENTS WITH LYMPHOID MALIGNANCIES

EHA Library, Lori Muffly MD MS, 215964

FOXP3 KNOCKDOWN INHIBITS THE PROLIFERATION AND REDUCES NOTCH1 EXPRESSION OF T- LYMPHOBLASTIC LEUKEMIA CELLS

EHA Library, Satoru Yonekura, 215930

IMMEDIATE AND LONG-TERM OUTCOMES OF SPLENECTOMY IN PATIENTS WITH NON-HODGKIN LYMPHOMA AND CHRONIC LYMPHOCYTIC LEUKEMIA COMPLICATED BY AUTOIMMUNE HEMOLYTIC ANEMIA

EHA Library, Yurij Yevstakhevych, 215966

DYNAMIC CHANGES IN HLA-DR EXPRESSION DURING SHORT-TERM AND LONG-TERM IBRUTINIB TREATMENT IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Peter Turcsayni, 215967

METHOD COMPARISON OF A NOVEL SLIDE-BASED INTEGRATED HEMATOLOGY ANALYZER AND A FLOW CYTOMETRY-BASED SYSTEM USING SAMPLES WITH TARGETED MEDICAL CONDITIONS

EHA Library, Henk Russcher, 215968

THE VALUE OF RITUXIMAB-CONTAINING CHEMOTHERAPY IN SECOND-LINE WITH OR WITHOUT PREVIOUS RITUXIMAB EXPOSURE: A POPULATION-BASED STUDY AMONG PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA IN THE NETHERLANDS

EHA Library, Lina van der Straten, 215969

PROSPECTIVE REAL WORLD DATA OF AN ONGOING POST-AUTHORIZATION SAFETY STUDY ON IDELALISIB IN PATIENTS WITH CLL AND REFRACTORY FL

EHA Library, Wolfgang Knauf, 215970

COPY NUMBER ALTERATIONS DETECTED BY A MULTIPLEX PCR GENOTYPING METHOD AND FISH IN CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Lei Fan, 215971

MAINTENANCE DOSING OF IBRUTINIB FOR CHRONIC LYMPHOCYTIC LEUKAEMIA (CLL) / SMALL LYMPHOCYTIC LYMPHOMA PATIENTS

EHA Library, Raj Ramakrishna, 215972

SECOND CANCERS IN CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS TREATED WITH BCR INHIBITORS – RETROSPECTIVE ANALYSIS OF THE POLISH ADULT LEUKEMIA STUDY GROUP (PALG)

EHA Library, Krzysztof Jamroziak, 215973

IL-2, IL-6, IL-17 AND IL-33 IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA COMPLICATED BY AUTOIMMUNE CYTOPENIAS

EHA Library, Olha Vyhovska, 215974

PGP AND BCRP INHIBITOR AS A MODULATOR OF IMATINIB RESISTANCE

EHA Library, Ana Bela Sarmento-Ribeiro, 215975

KILLER IMMUNOGLOBULIN-LIKE RECEPTOR GENOTYPES IN TURKISH PATIENTS WITH ACUTE AND CHRONIC MYELOID LEUKEMIA

EHA Library, Emel Gürkan, 215976

HEAT SOCK PROTEIN 90 INHIBITION AS A POTENTIAL THERAPEUTIC TARGET IN CHRONIC MYELOID LEUKEMIA

EHA Library, Ana Bela Sarmento-Ribeiro, 215977

A MATHEMATICAL APPROACH TOWARDS IMMUNOLOGICAL CONTROL OF MINIMAL RESIDUAL DISEASE IN CML PATIENTS

EHA Library, Ingmar Glauche, 215978

EVOLUTION OF PLASMA LEVELS, RESPONSE AND TOLERANCE TO IMATINIB AFTER SWITCHING FROM GLIVEC® TO GENERIC IMATINIB IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA IN CHRONIC PHASE (CML-CP)

EHA Library, Juan Luis Steegmann, 215979

IS THE TIME TO CYTOGENETIC RESPONSE PREDICTIVE FOR SURVIVAL IN CHRONIC MYELOID LEUKEMIA? POPULATION DATA FROM RUSSIAN CML REGISTRY AND SIMULATION MODEL.

EHA Library, Sergey Kulikov, 215980

EPIDEMIOLOGY IN CHRONIC MYELOID LEUKEMIA (CML) IN ANDALUSIA (SPAIN). RESULTS FROM THE ANDALUSIAN REGISTRY OF CML (RALMC) 2002-2016.

EHA Library, Jose Manuel Puerta-Puerta, 215981

EFFECTIVENESS IN REAL LIFE OF TKI TREATMENT ON CML. RESULTS FROM THE ANDALUSIAN REGISTRY OF CHRONIC MYELOID LEUKEMIA (RALMC) 2002-2016.

EHA Library, Jose Manuel Puerta-Puerta, 215982

TARGET: A SURVEY OF REAL-WORLD MANAGEMENT OF CHRONIC MYELOID LEUKEMIA ACROSS 33 COUNTRIES

EHA Library, Anna turkina, 215983

SURVIVAL AFTER 1, 3 AND 5 YEARS OF TYROSINE KINASE INHIBITOR THERAPY IN SIMPLICITY, AN OBSERVATIONAL STUDY OF CHRONIC-PHASE CHRONIC MYELOID LEUKEMIA (CP-CML) PATIENTS IN ROUTINE CLINICAL PRACTICE

EHA Library, Mauricette Michallet, 215984

IMPACT OF AGE ON THE CLINICAL RESPONSE, TOXICITY AND SURVIVAL IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA TREATED WITH IMATINIB IN THE FIRST-LINE: AN ANALYSIS OF CAMELIA REGISTRY.

EHA Library, Edgar Faber, 215985

AGE-RELATED BACH2/PRDM1 GENE EXPRESSION ALTERATIONS IN T AND B LYMPHOCYTES FROM CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS AND AGE-MATCHED HEALTHY DONORS.

EHA Library, Pushpamali De Silva, 215960

DO LEUKAPHERESIS IMPROVE EARLY DEATH RATES IN ACUTE MYELOID LEUKEMIA PATIENTS WITH HYPERLEUKOCYTOSIS?

EHA Library, Osman Ilhan, 215959

THE ROLE OF MUTATIONS OF THE GENE FLT3 IN ACUTE MYELOID LEUKEMIA: THE EFFECT ON THE COURSE OF THE DISEASE AND THE RESULTS OF THE THERAPY

EHA Library, Asiyat Radzhabova, 215958

A SUBSET OF AML PATIENTS SHOWS DIFFERENT QUIMIOSENSITIVY EX VIVO PROFILES TO ANTHRACYCLINES AND ITS COMBINATION WITH CYTARABINE; COULD PRECISION MEDICINE BE THE KEY SELECTION CRITERION?

EHA Library, Joan Ballesteros, 215957

FEASIBILITY AND SAFETY OF AN EARLY INTENSIFICATION APPROACH WITH FLAG-IDA IN NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA (AML) PATIENTS WITH MORPHOLOGICAL RESIDUAL LEUKEMIA AT DAY 14 BONE MARROW AFTER 3+7.

EHA Library, Francesca Pavesi, 215954

EFFICACY AND SAFETY OF C-CAG REGIMEN (CLADRIBINE,G-CSF, LOW-DOSE CYTARABINE AND ACLARUBICIN) IN PATIENTS WITH REFRACTORY/RELAPSED ACUTE MYELOID LEUKEMIA: A PHASE 2, SINGLE CENTER, SINGLE ARM STUDY.

EHA Library, yue lu, 215953

HEALTH RELATED QUALITY OF LIFE (HRQOL) IN ACUTE MYELOID LEUKEMIA (AML) PATIENTS NOT ELIGIBLE FOR INTENSIVE CHEMOTHERAPY (NIC AML): RESULTS OF A SYSTEMATIC LITERATURE REVIEW

EHA Library, Anna Forsythe, 215952

EFFECT OF A HIGH-FAT AND HIGH-CALORIE MEAL ON THE PHARMACOKINETICS (PK) OF QUIZARTINIB (Q) AND ITS ACTIVE METABOLITE

EHA Library, Jianke Li, 215951

A DRUG-DRUG INTERACTION STUDY TO ASSESS THE EFFECT OF ACID REDUCING AGENT, LANSOPRAZOLE, ON QUIZARTINIB PHARMACOKINETICS

EHA Library, Jianke Li, 215950

OUTCOME PREDICTION OF AML PATIENTS SUBMITTED TO ALLOGENEIC STEM CELL TRANSPLANTATION IN RECENT YEARS. A SINGLE CENTER EXPERIENCE ON 101 PATIENTS.

EHA Library, Nicola Polverelli, 215949

ALTERATIONS IN SERUM BILIRUBIN DURING TREATMENT WITH ENASIDENIB IN PATIENTS WITH OR WITHOUT UGT1A1 MUTATIONS

EHA Library, Amir T. Fathi, 215948

IMPROVING RISK STRATIFICATION IN ACUTE MYELOID LEUKEMIA WITH MRNA TECHNIQUES: BAALC AND WT1 LEVELS AFTER INDUCTION ARE BETTER THAN MORPHOLOGIC STATUS POST INDUCTION AND CYTOGENETIC AT DIAGNOSIS.

EHA Library, Carlos Rodríguez Medina, 215946

DIFFERENTIAL GENE EXPRESSION PROFILE ALTERATIONS IN CHEMORESISTANT AML CELLS FOLLOWING THEIR EXPOSURE TO IDARUBICIN AND CYTARABINE

EHA Library, Vassiliki Pappa, 215945

SUCCESSFUL COVERAGE OF DIFFICULT TO SEQUENCE GENES (CALR, CEBPA, AND FLT3) ASSOCIATED WITH MYELOID DISORDERS USING A HYBRIDISATION-BASED ENRICHMENT APPROACH PRIOR TO NEXT-GENERATION SEQUENCING (NGS).

EHA Library, Lyudmila Georgieva, 215944

LOW-MYELOPEROXIDASE (MPO) MIXED-PHENOTYPE ACUTE LEUKEMIAS (MPALS) IDENTIFIED BY COMBINING CYTOCHEMISTRY AND FLOW CYTOMETRY

EHA Library, George Paterakis, 215943

ANTITUMOR ACTIVITY OF BIBR1532, A SELECTIVE SMALL MOLECULE INHIBITOR OF TELOMERASE, IRRESPECTIVE OF P53 STATUS OF TUMOR CELLS

EHA Library, Atieh Pourbagheri-Sigaroodi, 215942

ADAM28 AGGRAVATES THE LEUKEMIA BURDEN IN A MICE MODEL AND PREDICTED A HIGH RISK OF RELAPSE IN FAVORABLE-RISK AML PATIENTS

EHA Library, Jia-Min Zhang, 215941

CHONDROITIN SULPHATE PROTEOGLYCAN 4 POTENTIAL MARKER OF MINIMAL RESIDUAL DISEASE IN ACUTE MYELOID LEUKEMIA AND BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASM

EHA Library, Miloslava Hisemová, 215940

ALLOGENEIC STEM CELL TRANSPLANTATION FOR PHILADELPHIA-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Hanane Bouarab, 215939

VENOUS THROMBOEMBOLISM IN PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) TREATED WITH ERYASPASE (L-ASPARAGINASE ENCAPSULATED IN RED BLOOD CELLS)

EHA Library, Yves Bertrand, 215938

EFFECTS OF IRON OVERLOAD IN CHILDREN WITH ALL

EHA Library, Katerina Bruslova, 215937

THE TREATMENT OUTCOME OF CHILDREN WİTH ACUTE LYMPHOBLASTIC LEUKEMIA:20 YEARS EXPERIENCE FROM A SINGLE CENTER IN TURKEY

EHA Library, ADALET MERAL GÜNEŞ, 215936

HEPATITIS C VIRUS INFECTION-ASSOCIATED MACROPHAGE ACTIVATION SYNDROME IN A PEDIATRIC PATIENT WHICH UNDERWENT HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Mariacristina Menconi, 215935

SEQUENTIAL USE OF IMMUNOTHERAPY IN REFRACTORY/RELAPSED B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA: CLINICAL EXPERIENCE FROM A SINGLE-CENTRE

EHA Library, Nicola Stefano Fracchiolla, 215934

NOTCH PATHWAY AS A THERAPEUTIC TARGET IN ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Ana Bela Sarmento-Ribeiro, 215933

PARTHENOLIDE, AN NF-ΚB INHIBITOR, INDUCE CELL DEATH AND SUPPRESS CELL PROLIFERATION IN LYMPHOID MALIGNANCIES

EHA Library, Ana Bela Sarmento Ribeiro, 215932

INHIBITION OF DNA-PK ENHANCES CHEMOSENSITIVITY OF B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA CELLS TO DOXORUBICIN

EHA Library, Majid Safa, 215931

EPIGENETIC MODULATORS SHOW IN VITRO THERAPEUTIC POTENTIAL TO TREAT B CELL ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Ana Bela Sarmento Ribeiro, 215929

MITIGATION OF TUMOR LYSIS SYNDROME (TLS) COMPLICATIONS WITH VENETOCLAX (VEN) IN CLL

EHA Library, John F. Seymour, 215965